On Conducting Burden-of-Osteoporosis Studies: A Review of the Core Concepts and Practical Issues. A Study Carried out under the Auspices of a Who Collaborating Center
Ben Sedrine, Wafa; Radican, L.; Reginster, Jean-Yves
On Conducting Burden-of-Osteoporosis Studies A Review of the Core Concepts and Practical Issues. A Study Carried out under the Auspices of a Who Collaborating Center.pdf
Cost of Illness; Costs and Cost Analysis; Humans; Osteoporosis/economics/epidemiology; World Health Organization
Abstract :
[en] Osteoporosis is a problem that is relevant to public health from the clinical, economic and social viewpoints. Except in a handful of industrialized countries, there is a considerable void in our knowledge of the magnitude of the problem. By exploring both the epidemiological and the economic impact of osteoporosis and the fractures associated with it in a particular country, studies of the 'burden of illness' (BOI) can fill that void. BOI analysis raises many questions at both the conceptual and the practical level. The purpose of this paper is to review the methodology underlying analyses of this type, to discuss its limitations and to provide a general format to improve their implementation in the field of osteoporosis. Investigators involved in BOI analysis should be very clear and explicit regarding the methods they adopt, so that studies in different countries can be interpreted and compared appropriately by interested parties.
Disciplines :
Special economic topics (health, labor, transportation...) Public health, health care sciences & services Rheumatology
Author, co-author :
Ben Sedrine, Wafa ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Radican, L.
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
On Conducting Burden-of-Osteoporosis Studies: A Review of the Core Concepts and Practical Issues. A Study Carried out under the Auspices of a Who Collaborating Center
Diagnosis, prophylaxis and treatment of osteoporosis (1991) Am J Med, 90, pp. 107-110. , Consensus Development Conference
Melton III, L.J., How many women have osteoporosis now? (1995) J Bone Miner Res, 10, pp. 175-177
Cooper, C., Campion, G., Melton III, L.J., Hip fractures in the elderly: A world-wide projection (1992) Osteoporosis Int, 2, pp. 285-289
Cooper, C., Atkinson, E.J., Jacobsen, S.J., O'Fallon, W.M., Melton III, L.J., Population-based study of survival following osteoporotic fractures (1993) Am J Epidemiol, 137, pp. 1001-1005
Ray, N.F., Chan, J.K., Thamer, M., Melton III, L.J., Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation (1997) J Bone Miner Res, 12, pp. 24-35
Reginster, J.Y., Gillet, P., Ben Sedrine, W., Direct costs of hip fractures in patients over 60 years old, in Belgium (1999) Pharmacoeconomics, 15, pp. 507-514
(1990), Office of Health Economics. Osteoporosis and the risk of fracture. London: Office of Health Economics
Lyritis, G., Epidemiology and socioeconomic cost of osteoporotic fractures in Greece (1992) Calcif Tissue Int, 51, pp. 93-94
Simonen, O., Epidemiology and socioeconomic aspects of osteoporosis in Finland (1988) Ann Chir Gynaecol, 77, pp. 173-175
Lane, A., Direct costs of osteoporosis for New Zealand women (1996) Pharmacoeconomics, 9, pp. 231-245
Lippuner, K., von Overbeck, J., Perrelet, R., Bosshard, H., Jaeger, P., Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland (1997) Osteoporosis Int, 7, pp. 414-425
Lopez Vaz, A., Epidemiology and costs of osteoporotic hip fractures in Portugal (1993) Bone, 14 (SUPPL.), pp. S9-S10
Zethraeus, N., Strömberg, L., Jönsson, B., Svensson, O., Öhlen, G., The cost of a hip fracture. Estimates for 1709 patients in Sweden (1997) Acta Orthop Scand, 68, pp. 13-17
Gullberg, B., Johnell, O., Kanis, J.A., Worldwide projections for hip fracture (1997) Osteoporosis Int, 7, pp. 407-441
Melton III, L.J., Hip fractures: A worldwide problem today and tomorrow (1993) Bone, 14 (SUPPL.), pp. S1-S8
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994), WHO Study Group. Technical Report Series, No. 843. Geneva: World Health Organization
Shiell, A., Donaldson, G.K., Cost of illness studies: An aid to decision-making? (1987) Health policy, 8, pp. 317-323
Drummond, M., Cost of illness studies. A major headache? (1992) Pharmacoeconomics, 2, pp. 1-4
Hodgson, T.A., Cost of illness studies: No aid to decision-making? Comments on the second opinion by Shiell et al (1989) Health Policy, 11, pp. 57-60
Koopmanschap, M.A., Cost of illness studies. Useful for health policy? (1998) Pharmacoeconomics, 14, pp. 143-148
Wiseman, V., Mooney, G., Burden of illness estimates for priority settings: A debate revisited (1998) Health Policy, 43, pp. 243-251
Marciniak, A., Ben Sedrine, W., Best, J., (1999), Recommendations for health economics evaluations of interventions in osteoporosis. WHO Collaborating Centre for Public Health Aspects of Osteoporosis and other Rheumatic Diseases, Liège, Belgium. Geneva: World Health Organization
Dere, W., Avouac, B., Boers, M., Recommendations for the health economics analysis to be performed with a drug to be registered in prevention or treatment of osteoporosis (1998) Calcif Tissue Int, 63, pp. 93-97
Hodgson, T.A., Cost of illness in cost-effectiveness analysis. A review of the methodology (1994) Pharmacoeconomics, 6, pp. 536-552
Byford, S., Palmer, S., Common errors and controversies in pharmacoeconomic analyses (1998) Pharmacoeconomics, 13, pp. 659-666
Finkler, S.A., The distinction between costs and charges (1982) Ann Intern Med, 96, pp. 102-109
Grenier, B., (1996), Evaluation de la décision médicale. Introduction à l'analyse médico-économique, 2nd edn. Paris: Masson
Drummond, M.F., O'Brien, B.J., Stoddard, G.L., Torrance, G.W., (1997), Methods for economic evaluation of health care programmes, 2nd edn. Oxford: Oxford University Press
Weinstein, M.C., Siegel, J.E., Gold, M.R., Kamlet, M.S., Russell, L.B., Recommendations of the panel on cost-effectiveness in health and medicine (1996) J Am Med Assoc, 276, pp. 1253-1258
(1995), Australian Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee, including major economic analyses. Canberra: Australian Government Publishing Service
(1994), Canadian Coordinating Office for Health Technology Assessment (CCHOTA). Guidelines for economic evaluation of pharmaceuticals, 1st edn. Ottawa: CCHOTA
Gold, M.R., Siegel, J.E., Russel, L.B., Weistein, M.C., (1996), Cost-effectiveness in health and medicine. Oxford: Oxford University Press
Johannesson, M., Karlsson, G., The friction cost method: A comment (1997) J Health Econ, 16, pp. 249-255
Rothermich, E.A., Pathak, D.S., Productivity-cost controversies in cost-effectiveness analysis: Review and research agenda (1999) Clin Ther, 21, pp. 255-267
Koopmanschap, M.A., Rutten, F.A., Practical guide for calculating indirect costs of disease (1996) Pharmacoeconomics, 10, pp. 460-466
Rice, D.P., Estimating the cost of illness (1966), Health Economics Series, No. 6. Washington, DC: US Government Printing Office
Harturian, N.S., Smart, C.N., Thompson, M.S., The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease and stroke: A comparative analysis (1980) Am J Public Health, 70, pp. 1249-1260
Phillips Fox, N., Jacobs, J., Wright, W.E., The direct medical costs of osteoporosis for American women aged 45 and older, 1986 (1988) Bone, 9, pp. 271-279
Melton III, L.J., Thamer, M., Ray, N.F., Fractures attributable to osteoporosis: Report from the National Osteoporosis Foundation (1997) J Bone Miner Res, 12, pp. 16-23